BHEKISISA : Anti-HIV jab due in six weeks but funding cuts hollow out delivery system

The uptake of the once-every-six-month HIV prevention jab lenacapavir (LEN) in South Africa will be heavily affected by the Trump administration’s funding cuts to the country, a new report has found. Researchers conducted in-depth interviews with doctors, nurses, peer counsellors, transgender (…)